These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23632404)

  • 1. Comparison of acetazolamide, brimonidine, and anterior chamber paracentesis for ocular hypertension control after initial intravitreal bevacizumab injection: a randomized clinical trial.
    Katayama BY; Bonini-Filho MA; Messias AM; Paula JS; Martin LF; Costa R; Jorge R
    J Glaucoma; 2014 Sep; 23(7):461-3. PubMed ID: 23632404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypotensive efficacy of topical brimonidine for intraocular pressure spikes following intravitreal injections of antivascular endothelial growth factor agents: a randomised crossover trial.
    Felfeli T; Hostovsky A; Trussart R; Yan P; Brent MH; Mandelcorn ED
    Br J Ophthalmol; 2019 Oct; 103(10):1388-1394. PubMed ID: 30573499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EFFECT OF SERIAL ANTERIOR CHAMBER PARACENTESIS ON SUSTAINED INTRAOCULAR PRESSURE ELEVATION IN PATIENTS RECEIVING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
    Sisk RA; Rusia D; Zamora BG; Kuley A; Toussaint BW
    Retina; 2019 Oct; 39(10):1959-1964. PubMed ID: 30234855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prophylactic medication and influence of vitreous reflux in pressure rise after intravitreal injections of anti-VEGF drugs.
    Carnota-Méndez P; Méndez-Vázquez C; Otero-Villar J; Saavedra-Pazos JA
    Eur J Ophthalmol; 2014; 24(5):771-7. PubMed ID: 24706353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.
    Frenkel MP; Haji SA; Frenkel RE
    Arch Ophthalmol; 2010 Dec; 128(12):1523-7. PubMed ID: 21149773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: a prospective study.
    Soheilian M; Karimi S; Montahae T; Nikkhah H; Mosavi SA
    Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1705-1712. PubMed ID: 28616715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anterior chamber paracentesis might prevent sustained intraocular pressure elevation after intravitreal injections of ranibizumab for age-related macular degeneration.
    Ichiyama Y; Sawada T; Kakinoki M; Sawada O; Nakashima T; Saishin Y; Kawamura H; Ohji M
    Ophthalmic Res; 2014; 52(4):234-8. PubMed ID: 25401265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracentesis before intravitreal injection of bevacizumab.
    Tsui YP; Chiang CC; Tsai YY
    Can J Ophthalmol; 2008 Apr; 43(2):239; author reply 239-40. PubMed ID: 18347632
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections].
    El Chehab H; Le Corre A; Giraud JM; Ract-Madoux G; Swalduz B; Dot C
    J Fr Ophtalmol; 2012 Oct; 35(8):614-21. PubMed ID: 22832030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of topical pressure-lowering medication on prevention of intraocular pressure spikes after intravitreal injection.
    El Chehab H; Le Corre A; Agard E; Ract-Madoux G; Coste O; Dot C
    Eur J Ophthalmol; 2013; 23(3):277-83. PubMed ID: 23161177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Dorzolamide/Timolol or Brinzolamide/Timolol prophylaxis on intravitreal anti-VEGF injection-induced intraocular hypertension.
    Kim GN; Han YS; Chung IY; Seo SW; Park JM; Yoo JM
    Semin Ophthalmol; 2013 Mar; 28(2):61-7. PubMed ID: 23448557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients.
    Murray CD; Wood D; Allgar V; Walters G; Gale RP
    Eye (Lond); 2014 Oct; 28(10):1218-22. PubMed ID: 25081290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effects of intravitreal bevacizumab on cornea and anterior chamber.
    Güler M; Capkın M; Simşek A; Bilak S; Bilgin B; Hakim Reyhan A; Fırat M
    Curr Eye Res; 2014 Oct; 39(10):989-93. PubMed ID: 24588314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent elevation of intraocular pressure following intravitreal injection of bevacizumab.
    Segal O; Ferencz JR; Cohen P; Nemet AY; Nesher R
    Isr Med Assoc J; 2013 Jul; 15(7):352-5. PubMed ID: 23943979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Topical application of hypotensive drugs for the prevention of intraocular pressure elevation after intravitreal injections of anti-VEGF drugs].
    Andreeva YS; Alkharki L; Shelankova AV; Budzinskaya MV
    Vestn Oftalmol; 2024; 140(2. Vyp. 2):73-79. PubMed ID: 38739134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dorzolamide/timolol versus brimonidine/timolol fixed combination therapy in the management of steroid-induced ocular hypertension.
    Seymenoğlu G; Baser EF; Öztürk B; Gülhan C
    J Glaucoma; 2015 Feb; 24(2):111-6. PubMed ID: 23807349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immediate changes in intraocular pressure after an intravitreal injection of 2.5 mg of bevacizumab].
    Wu L; Evans T
    Arch Soc Esp Oftalmol; 2010 Nov; 85(11):364-9. PubMed ID: 21277463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained elevated intraocular pressures after intravitreal injection of bevacizumab, ranibizumab, and pegaptanib.
    Choi DY; Ortube MC; McCannel CA; Sarraf D; Hubschman JP; McCannel TA; Gorin MB
    Retina; 2011 Jun; 31(6):1028-35. PubMed ID: 21836409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pegaptanib injections on intraocular pressure with and without anterior chamber paracentesis: a prospective study.
    Knip MM; Välimäki J
    Acta Ophthalmol; 2012 May; 90(3):254-8. PubMed ID: 20456259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring intraocular pressure changes after intravitreal Ranibizumab injection using rebound tonometry.
    Fuest M; Kotliar K; Walter P; Plange N
    Ophthalmic Physiol Opt; 2014 Jul; 34(4):438-44. PubMed ID: 24731161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.